- Home
- PLX vs GENC Comparison
PLX vs GENC Comparison
Compare PLX & GENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- GENC
- Stock Information
- Founded
- PLX 1993
- GENC 1894
- Country
- PLX Israel
- GENC United States
- Employees
- PLX N/A
- GENC N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- GENC Construction/Ag Equipment/Trucks
- Sector
- PLX Health Care
- GENC Industrials
- Exchange
- PLX Nasdaq
- GENC Nasdaq
- Market Cap
- PLX 160.2M
- GENC 181.9M
- IPO Year
- PLX 1998
- GENC N/A
- Fundamental
- Price
- PLX $2.59
- GENC $12.23
- Analyst Decision
- PLX Strong Buy
- GENC
- Analyst Count
- PLX 1
- GENC 0
- Target Price
- PLX $15.00
- GENC N/A
- AVG Volume (30 Days)
- PLX 764.3K
- GENC 36.7K
- Earning Date
- PLX 03-17-2025
- GENC 05-09-2025
- Dividend Yield
- PLX N/A
- GENC N/A
- EPS Growth
- PLX N/A
- GENC 35.02
- EPS
- PLX 0.04
- GENC 1.11
- Revenue
- PLX $53,399,000.00
- GENC $113,116,000.00
- Revenue This Year
- PLX $67.17
- GENC N/A
- Revenue Next Year
- PLX $55.31
- GENC N/A
- P/E Ratio
- PLX $71.07
- GENC $10.99
- Revenue Growth
- PLX N/A
- GENC 5.44
- 52 Week Low
- PLX $0.82
- GENC $11.65
- 52 Week High
- PLX $2.76
- GENC $24.88
- Technical
- Relative Strength Index (RSI)
- PLX 58.97
- GENC 40.67
- Support Level
- PLX $2.43
- GENC $11.65
- Resistance Level
- PLX $2.62
- GENC $13.11
- Average True Range (ATR)
- PLX 0.14
- GENC 0.70
- MACD
- PLX 0.02
- GENC -0.01
- Stochastic Oscillator
- PLX 85.00
- GENC 21.16
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About GENC Gencor Industries Inc.
Gencor Industries Inc and its subsidiaries is a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company has one reporting segment, equipment for the highway construction industry. The firm's principal products include asphalt plants, combustion systems, hot mix asphalt plants, fluid heat transfer systems, and asphalt pavers.